Patient-reported outcome measure of the quality of life in Ugandans living with autoimmune rheumatic diseases

Aim of the work: To assess the patient reported outcome measure (PROM) of the quality of life (QoL) of patients with autoimmune rheumatic diseases (RDs) attending two tertiary care rheumatology clinics in Uganda

Bibliographische Detailangaben
Veröffentlicht in:The Egyptian rheumatologist. - 1998. - 43(2021), 3 vom: 02. Juni, Seite 203-207
1. Verfasser: Bongomin, Felix (VerfasserIn)
Weitere Verfasser: Sekimpi, Maria, Natukunda, Barbra, Makhoba, Anthony, Kaddumukasa, Mark
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2021
Zugriff auf das übergeordnete Werk:The Egyptian rheumatologist
Schlagworte:Journal Article Autoimmune rheumatic diseases DMARDs Health index Patient-reported outcomes Rheumatoid arthritis SLE Uganda
Beschreibung
Zusammenfassung:Aim of the work: To assess the patient reported outcome measure (PROM) of the quality of life (QoL) of patients with autoimmune rheumatic diseases (RDs) attending two tertiary care rheumatology clinics in Uganda
Patients and methods: Patients with a confirmed diagnosis of RD and receiving disease modifying anti-rheumatic drugs (DMARDs) were studied. Health index and overall self-rated health status were assessed using the EuroQol 5-dimension (ED-5D-5L) questionnaire tool
Results: 74 patients were studied: 48 (64.9%) had rheumatoid arthritis (RA), 14(18.9%) systemic lupus erythematosus (SLE), and 12(16.2%) had other RDs; spondyloarthritis (n = 5), systemic sclerosis (n = 3), juvenile idiopathic arthritis (n = 2), and idiopathic inflammatory myositis (n = 2). Their mean age was 45 ± 17 years and 69 (93.2%) were female. 14(18.9%) were on concomitant herbal medication and 26 (35.1%) self-reported at least 1 adverse drug reaction. Any level of problem was reported by 54(72.5%) participants for mobility, 47(63.5%) for self-care, 56(75.6%) for usual activity, 66(89.1%) for pain and discomfort, and 56(75.6%) for anxiety/depression. The mean health index of the patients was 0.64 ± 0.16 and the overall self-rated health status was 58.1 ± 16.7. Patients with SLE (0.74 ± 0.12) had higher health index compared to those with RA (0.60 ± 0.17) or other RDs (0.70 ± 0.1) (p < 0.007). Overall self-rated health status was comparable across clinical diagnoses (p = 0.23). Both the index and self-reported status were better for patients who received private hospital care compared to public hospital (p < 0.0001 and p = 0.01)
Conclusion: There is a substantial negative impact of autoimmune rheumatic diseases on quality of life of patients, especially those receiving care from a public facility in Uganda
Beschreibung:Date Revised 27.08.2022
published: Print-Electronic
Citation Status PubMed-not-MEDLINE
ISSN:2090-2433
DOI:10.1016/j.ejr.2021.02.004